VG801 is a dual AAV gene therapy that leverages mRNA trans-splicing via the vgRNA REVeRT and vgAAV platforms to deliver the full-length ABCA4 gene for Stargardt disease and related retinal disorders.
Listings for all local, national and international meetings, conferences and where the Academy exhibits
Boyer discusses a potential treatment for diabetic retinopathy and macular degeneration using suprachoroidal injections, offering reduced risks and improved outcomes.
Increases in transient visual disturbances are seen during pregnancy, the COVID-19 pandemic may have increased the risk of astigmatism, and certain factors could contribute to…
OCU400 is Ocugen’s novel modifier gene therapy for retinitis pigmentosa (RP).
This cohort study examines whether a diagnosis of primary open-angle glaucoma in patients with ocular hypertension is associated with a decrease in mental health.
A recent population-based cohort study has identified a significant association between the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and an increased risk of developing…
Read articles appearing in the print edition of Ocular Surgery News U.S. Edition. Healio is your trusted source for medical news.
Listings for all local, national and international meetings, conferences and where the Academy exhibits
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.
To evaluate the effect of corneal cross-linking (CXL) on corneal neovascularization (CNV) between eyes that were randomized to receive either CXL or non-CXL donor corneas…
